A randomized phase III double-blinded placebo-controlled trial of Aspirin as adjuvant therapy for Breast Cancer (Alliance A011502): The Aspirin after Breast Cancer (ABC) Trial
- Citation:
- J Clin Oncol vol 40 (36_suppl) 360922
- Meeting Instance:
- ASCO PS - Feb 2022
- Year:
- 2022
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 4084
- Pharmas:
- Bayer
- Grants:
- U10CA180821, U10CA180882, U10CA180868 (NRG)
- Corr. Author:
- Authors:
- Wendy Chen Karla V. Ballman Eric P. Winer Michelle Holmes Carol Matyka Margaret Carvan Anna Weiss Olwen Hahn William Irvin Jr Paula Pohlmann Fred Briccetti Ann Partridge Linda McCall Thomas Openshaw
- Networks:
- LAPS-CT018, LAPS-IL057, LAPS-MA036, LAPS-TX035, ME040, NH038, NY167, SCOR
- Study
- Alliance-A011502
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: